Methylation and histone deacetylase inhibition in combination with platinum treatment in patients with advanced malignancies

Por Falchook, Gerald S., Fu, Siqing, Naing, Aung, Hong, David S., Hu, Wei, Moulder, Stacy, Wheler, Jennifer J., Sood, Anil K., Bustinza-Linares, Ernesto, Parkhurst, Kristin L., Kurzrock, Razelle
Publicado em 2013

Dual antiangiogenic inhibition: a phase I dose escalation and expansion trial targeting VEGF-A and VEGFR in patients with advanced solid tumors

Por Falchook, Gerald S., Wheler, Jennifer J., Naing, Aung, Piha-Paul, Sarina A., Fu, Siqing, Tsimberidou, Apostolia M., Hong, David S., Janku, Filip, Zinner, Ralph, Jiang, Yunfang, Huang, Mei, Lin, Quan, Parkhurst, Kristin, Kurzrock, Razelle
Publicado no Invest New Drugs (2014)

A phase I trial of combination trastuzumab, lapatinib, and bevacizumab in patients with advanced cancer

Por Falchook, Gerald S., Moulder, Stacy, Naing, Aung, Wheler, Jennifer J., Hong, David S., Piha-Paul, Sarina A., Tsimberidou, Apostolia M., Fu, Siqing, Zinner, Ralph, Janku, Filip, Jiang, Yunfang, Huang, Mei, Parkhurst, Kristin L., Kurzrock, Razelle
Publicado no Invest New Drugs (2014)

Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: A phase I trial of bortezomib plus bevacizumab

Por Falchook, Gerald S, Wheler, Jennifer J, Naing, Aung, Jackson, Edward F, Janku, Filip, Hong, David, Ng, Chaan S, Tannir, Nizar M, Lawhorn, Kristie N, Huang, Mei, Angelo, Laura S, Vishwamitra, Deeksha, Hess, Kenneth, Howard, Adrienne N, Parkhurst, Kristin L, Amin, Hesham M, Kurzrock, Razelle
Publicado no Oncotarget (2014)